Chemical Structure : Belantamab
CAS No.: 2061894-48-0
货号: PC-Ab1042Not For Human Use, Lab Use Only.
B-cell maturation antigen (BCMA) is a cell-surface receptor of the tumour necrosis superfamily required for plasma cell survival. BMCA is universally detected on patient-derived myeloma cells and has emerged as a selective antigen to be targeted by novel treatments in multiple myeloma. Belantamab mafodotin (belamaf.
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥3580 | In stock | |
| 5 mg | ¥7580 | In stock | |
| 10 mg | ¥12800 | In stock | |
| 100 mg | Get quote | 
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
B-cell maturation antigen (BCMA) is a cell-surface receptor of the tumour necrosis superfamily required for plasma cell survival. BMCA is universally detected on patient-derived myeloma cells and has emerged as a selective antigen to be targeted by novel treatments in multiple myeloma. Belantamab mafodotin (belamaf; BLENREP, GSK2857916) is a first-in-class antibody–drug conjugate (ADC) that targets B-cell maturation antigen (BCMA).
| 分子量 | ||
| 分子式 | Human IgG1-Kappa | |
| 外观性状 | Solid | |
| 储存条件 | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             PBS, pH 7.0 Contains no stabilizers or preservatives  | 
                    |
| Chemical Name/SMILES | 
                             Belantamab; Belantamab mafodotin; 2061894-48-0;TNFRSF17; CD269; B-cell maturation antigen (BCMA); TNF Receptor Superfamily Member 17.  | 
                    |
1. 1, Tzogani K, et al. Oncologist. 2021 Jan;26(1):70-76. 2, Richardson PG, et al. Blood Cancer J. 2020 Oct 23;10(10):106. 3, Trudel S, et al. Lancet Oncol. 2018 Dec;19(12):1641-1653. 4, Lonial S, et al. Lancet Oncol. 2020 Feb;21(2):207-221.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright